title: Con: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
authors.forename: W Scott
authors.initials: WS
authors.lastname: Beattie
authors.forename: Keyvan
authors.initials: K
authors.lastname: Karkouti
mesh_terms: D000933:Antifibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D007611:Aprotinin / Q000009:adverse effects / Q000627:therapeutic use*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D006348:Cardiac Surgical Procedures; D002315:Cardiopulmonary Bypass; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D051437:Renal Insufficiency / Q000209:etiology
chemical_list: D000933:Antifibrinolytic Agents; D006490:Hemostatics; D007611:Aprotinin